-
Mashup Score: 17A patient co-led project to set care and research priorities for older adults with cancer - 23 day(s) ago
Older adults with cancer face unique challenges, including complex needs and systemic barriers to care. These factors affect their medical treatment decisions and overall quality of life, while caregivers face concurrent burdens. Building on a multi-phase, patient- and community-engaged project, this survey study aimed to validate and rank research and care priorities for older adults with cancer in British Columbia, Canada generated from our earlier work.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet
-
Mashup Score: 15
The clinical uptake of validated chemotherapy toxicity predictor tools for older adults with cancer remains low. In this qualitative study, we sought to evaluate oncologist perspectives on the acceptability, appropriateness, and feasibility of the Cancer and Aging Research Group (CARG) chemotherapy toxicity predictor tool.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Oncologist perspectives on the acceptability, appropriateness, and feasibility of the Cancer and Aging Research Group (CARG) chemotherapy toxicity prediction tool for older adults https://t.co/BLlxwCN0ix @guptaarjun90 @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG
-
-
Mashup Score: 1Analysing the use of unsupervised learning to identify symptom clusters in older adults receiving chemotherapy - 28 day(s) ago
We read with interest the article “Unsupervised learning to identify symptom clusters in older adults undergoing chemotherapy,” which offers valuable insights into the use of machine learning to stratify symptom burden in this vulnerable population [1]. The application of unsupervised clustering to patient-reported outcomes is a promising approach to understanding heterogeneity in symptom experiences. However, we wish to highlight two methodological concerns that may impact the validity and clinical significance of the study’s findings.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Analysing the use of unsupervised learning to identify symptom clusters in older adults receiving chemotherapy https://t.co/hLRhCAuOqk @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #Oncology #Chemotherapy
-
-
Mashup Score: 6Association of intraindividual variability in simple reaction time with balance and falls in older cancer survivors: A secondary analysis - 1 month(s) ago
Intraindividual reaction time variability (IIRV) is associated with physical function and falls in older cancer-free adults but has been minimally studied in aging cancer survivors. The aims of this study were (a) to assess the association of IIRV with physical function and falls in chemotherapy-treated cancer survivors, (b) to determine if this relationship varied between middle-aged and older cancer survivors, and (c) to determine if any associations are independent of reaction response central tendency (i.e., total reaction accuracy) and locomotor impairment.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Association of intraindividual variability in simple reaction time with balance and falls in older cancer survivors: A secondary analysis https://t.co/uJ8BMKqiZt @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #CancerSurvivor https://t.co/m1wpYPzdFg
-
-
Mashup Score: 13Nurse navigation for older adults with cancer: A scoping review - 2 month(s) ago
Nurse navigation is important in cancer care, with prior studies indicating improvements in quality of life and symptom management. We sought to understand the scope of literature on nurse navigation for older adults with cancer. Specifically, we aimed to understand the characteristics, roles, and services nurse navigators provide for older adults with cancer.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Nurse navigation for older adults with cancer: A scoping review https://t.co/CwaBO3Diml @martine_puts @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #OncologyNursing #PatientNavigation https://t.co/1PDyNTnp46
-
-
Mashup Score: 13Nurse navigation for older adults with cancer: A scoping review - 2 month(s) ago
Nurse navigation is important in cancer care, with prior studies indicating improvements in quality of life and symptom management. We sought to understand the scope of literature on nurse navigation for older adults with cancer. Specifically, we aimed to understand the characteristics, roles, and services nurse navigators provide for older adults with cancer.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Nurse navigation for older adults with cancer: A scoping review https://t.co/CwaBO3Diml @martine_puts @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #OncologyNursing #PatientNavigation https://t.co/1PDyNTnp46
-
-
Mashup Score: 10Impact of geriatric assessment on decision-making for adjuvant chemotherapy in older patients with breast cancer - 2 month(s) ago
Breast cancer is the most common cancer affecting women worldwide, with its incidence increasing with age [1]. Studies have shown that age is an independent risk factor for nonreceipt of adjuvant systemic therapy [2]. Evidence for treating older women with breast cancer is sparse, as many clinical trials exclude patients over 65 due to comorbidities and other factors [3]. The current recommendations for adjuvant chemotherapy do not support differential use of specific chemotherapy drugs or dose reductions based on age [4].
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Impact of geriatric assessment on decision-making for adjuvant chemotherapy in older patients with breast cancer https://t.co/AYyapi0eQ4 @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier
-
-
Mashup Score: 33
As the global population ages, the incidence of cancer among older adults is expected to rise significantly, with projections indicating that by 2030, nearly 70 % of all cancer cases will be in individuals aged 65 and older. While decision-making on dosing of anticancer agents is a straightforward process in young and fit patients with cancer – considering the evidence from randomized clinical trials (RCTs) with cure or overall survival (OS) benefit as goal – in older adults it proves more challenging.
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
How to make recommendations on dosing for older adults receiving systemic cancer treatment – A holistic and pragmatic approach to decision-making with a focus on colorectal cancer https://t.co/xkLXDqxV0R @LipositsG @m_refaat8 @WilliamDale_MD @myCARG #GeriOnc #OlderAdults https://t.co/YOLfg6NTS3
-
-
Mashup Score: 11Representation of older adults in registrational trials associated with therapeutic approvals in diffuse large B-cell lymphoma - 2 month(s) ago
Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL) subtype, accounting for 30–40 % of all NHL cases globally [1]. DLBCL is predominantly a disease of older adults with a median age at diagnosis of 67 years. About a third of patients with newly diagnosed DLBCL are over 75 years of age [1]. Age over 60 is included in the International Prognostic Index as a risk factor for adverse prognosis [1]. The poor prognosis is also reflected in the fact that older patients continue to experience increased mortality even five years after diagnosis [2].
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Representation of older adults in registrational trials associated with therapeutic approvals in diffuse large B-cell lymphoma https://t.co/vVJwZQYWgA @PallawiTorkaMD @neuendorff_nr @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier https://t.co/wxovdL5D32
-
-
Mashup Score: 33
Over the years, the number of older adult patients with cancer has progressively increased. According to the GLOBOCAN 2022 database, half of all cancers are diagnosed in people ≥70 years. Lung cancer, with a median age at diagnosis of about 70 years, accounts for 12.4 % of all cancers worldwide and is also the leading cause of cancer death (18.7 %) [1]. The therapeutic proposal for older adult patients should not only be based on chronological age, but it should consider the functional age. Therefore, the International Society of Geriatric Oncology (SIOG) recommends performing a comprehensive geriatric assessment (CGA) to better evaluate the functional, psychological, cognitive, and nutritional status of patients [2].
Source: www.geriatriconcology.netCategories: General Medicine NewsTweet-
Association of G8 screening tool with prognosis and survival in patients with non-small cell lung cancer: A retrospective analysis from a single institution https://t.co/KfzhMLFiHM @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier #G8 #Screening https://t.co/rYQVod2ePZ
-
A patient co-led project to set care and research priorities for older adults with cancer https://t.co/oMfRbcRFia @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier https://t.co/oUi0FobVMA